v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Series A
Preferred stock
Series B
Preferred stock
Series C
Preferred stock
Common stock
Common stock to be issued
Additional paid-in capital
Non-controlling interest
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 7,435,000     $ 21,022,000   $ (33,571,000) $ (5,114,000)
Balance (in Shares) at Dec. 31, 2024 6,000 1,600,000   379          
Net Income (Loss)       (3,068,000) (3,068,000)
Shares issued for services     88,000   88,000
Shares issued for services (in Shares) 14,000   9          
Common stock issued for cash     95,000   95,000
Common stock issued for cash (in Shares)       470          
Prefunded warrants issued for cash     395,000   395,000
Prefunded warrants issued for cash (in Shares)       1,953          
Series B (cashless warrants)   $ 11,000   14,699,000   14,710,000
Series B (cashless warrants) (in Shares)   71,037          
Expenses relating to funding     (1,524,000)   (1,524,000)
Shares issued for acquisition   $ 3,000   2,997,000   3,000,000
Shares issued for acquisition (in Shares)   23,134          
Conversion of debt to equity     1,191,000   1,191,000
Conversion of debt to equity (in Shares)   176          
Shares issued for acquisition (Contingent Consideration)     400,000   400,000
Shares issued for acquisition (Contingent Consideration) (in Shares)   40          
Stock based compensation     36,000   36,000
Balance at Jun. 30, 2025 $ 7,435,000   $ 14,000   39,399,000   (36,639,000) 10,209,000
Balance (in Shares) at Jun. 30, 2025 20,000 1,600,000   97,198          
Balance at Mar. 31, 2025 $ 7,435,000     36,413,000   (35,272,000) 8,576,000
Balance (in Shares) at Mar. 31, 2025 20,000 1,600,000   1,074          
Net Income (Loss)       (1,367,000) (1,367,000)
Prefunded warrants issued for cash      
Prefunded warrants issued for cash (in Shares)       1,953          
Series B (cashless warrants)   $ 11,000   (11,000)  
Series B (cashless warrants) (in Shares)   71,037          
Shares issued for acquisition   $ 3,000   2,997,000   3,000,000
Shares issued for acquisition (in Shares)     23,134          
Balance at Jun. 30, 2025 $ 7,435,000   $ 14,000   39,399,000   (36,639,000) 10,209,000
Balance (in Shares) at Jun. 30, 2025 20,000 1,600,000   97,198          
Balance at Dec. 31, 2025 $ 7,435,000 $ 11,000 45,534,000 $ (37,000) (42,999,000) 9,944,000
Balance (in Shares) at Dec. 31, 2025 20,000 1,600,000 [1]   142,426          
Net Income (Loss)   (52,000) (10,563,000) (10,615,000)
Effects of exchange translation reserve (OCI)   73,000 73,000
Common stock and pre-funded warrants issued for acquisition [2] 12,000 12,000,000
Common stock and pre-funded warrants issued for acquisition (in Shares) [2]       55,682          
Preferred stock to be issued for acquisition [1],[2] 18,000,000   18,000,000
Common stock issued for cash   5,855,000 5,855,000
Common stock issued for cash (in Shares) [1]   696,621          
Equity line of credit – Prefunded warrants [3]           112,000     112,000
Conversion of debt to equity   10,167,000 10,167,000
Conversion of debt to equity (in Shares) [1]   451,437          
Equity issued pursuant to a financing arrangement   3,563,000 3,563,000
Equity issued pursuant to a financing arrangement (in Shares)       681,553          
Balance at Jun. 30, 2026 $ 7,435,000 $ 18,000,000 $ 11,000 12,000 [4] 65,231,000 (89,000) (53,489,000) 49,099,000
Balance (in Shares) at Jun. 30, 2026 20,000 1,600,000 [1] 2,027,719          
Balance at Mar. 31, 2026 $ 7,435,000 $ 18,000,000 $ 11,000 12,000 [4] 64,651,000 (61,000) (49,339,000) 52,697,000
Balance (in Shares) at Mar. 31, 2026 20,000 1,600,000 [1] 1,846,424          
Net Income (Loss)   (28,000) (4,387,000) (4,415,000)
Effects of exchange translation reserve (OCI)   237,000 237,000
Common stock issued for cash   468,000 468,000
Common stock issued for cash (in Shares) [1] 181,295          
Equity line of credit – Prefunded warrants           112,000     112,000
Balance at Jun. 30, 2026 $ 7,435,000 $ 18,000,000 $ 11,000 $ 12,000 [4] $ 65,231,000 $ (89,000) $ (53,489,000) $ 49,099,000
Balance (in Shares) at Jun. 30, 2026 20,000 1,600,000 [1] 2,027,719          
[1] The reverse stock splits effected in August 2025 and February 2026 applied to the Company’s common stock and did not affect the number of Series B Preferred Stock shares outstanding. Accordingly, the Series B Preferred Stock share balances presented herein reflect the 1,600,000 shares originally issued. This presentation has no impact on the carrying value of the Series B Preferred Stock or total stockholders’ equity. Also see Note 17, Subsequent Events.
[2] See note 6(B) for details on common stock and pre-funded warrants to be issued, in connection with the acquisition.
[3] See note 12(A)(ii) for details on equity line of credit – prefunded warrants.
[4] Previously shown as part of Additional Paid-in Capital.